Detecting Liver Infiltration in Lymphoma Patients Using MR Spectroscopy
Author Information
Author(s): R.M. Dixon, P.W. Angus, B. Rajagopalan, G.K. Radda
Primary Institution: MRC Biochemical and Clinical Magnetic Resonance Unit, and Nuffield Department of Medicine, John Radcliffe Hospital, Oxford, UK
Hypothesis
Can 31P MR spectroscopy detect biochemical changes in the liver due to lymphoma infiltration?
Conclusion
The study found that elevated PME/ATP and PME/Pi ratios in MR spectroscopy indicate liver involvement in lymphoma and can monitor treatment response.
Supporting Evidence
- Patients with liver involvement had elevated PME/ATP and PME/Pi ratios.
- After chemotherapy, patients with initially high ratios showed a decrease towards normal.
- Normal liver function tests did not always correlate with normal MR spectroscopy results.
Takeaway
Doctors can use a special scan to see if lymphoma is affecting the liver, which helps them decide on treatment.
Methodology
Patients with lymphoma underwent 31P MR spectroscopy of the liver, and results were compared with clinical assessments and imaging tests.
Limitations
The study did not perform liver biopsies for all patients, which may limit the confirmation of liver infiltration.
Participant Demographics
Patients included 8 with Hodgkin's disease and 14 with non-Hodgkin's lymphoma, with a mix of high and low-grade disease.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.01
Want to read the original?
Access the complete publication on the publisher's website